The American Society of Hypertension (abbreviated ASH) was an American non-profit professional society dedicated to advancing research on hypertension and related cardiovascular diseases.
The ASH was founded in 1985 by 17 scientists and physicians. In 2005, the ASH cut ties with the American Journal of Hypertension over a dispute over control of content published in the Journal. In 2006, the society became the center of a dispute over the appropriate role of pharmaceutical industry in medical research.
The dispute prompted several members of an ASH group convened to write a new definition of high blood pressure to resign from the group; those resigning included former ASH president Michael H. Alderman. In 2017, the society dissolved and merged with the American Heart Association. The Journal of the American Society of Hypertension, which was originally the official journal of the ASH, is now affiliated with the AHA.
American Society of Hypertension». NORD (National Organization for Rare Disorders). Retrieved 2018-09-25.
ALDERMAN, M; BANES, J; BLUMENFELD, J; GAVRAS, H; KURTZ, T; LARAGH, J; STEINER, S (July 2005). «The American Journal of Hypertension Withdraws from Its Affiliation with the American Society of Hypertension. A Report to Our Readers». American Journal of Hypertension. 18 (7): 893. doi:.1016/j.amjhyper..06.003.
Winslow, Ron (2005-07-29). «High Blood Pressure:Doctors Sever Ties With Medical Journal». The Wall Street Journal. Retrieved 2018-09-25.
Saul, Stephanie (2006-05-20). «Unease on Industry’s Role in Hypertension Debate». The New York Times. Retrieved 2018-09-25.
American Society of Hypertension and American Heart Association to Join Forces to Give a Voice to America’s «Silent Killer»». www.prnewswire.com (Press release). 2017-07-11. Retrieved 2018-09-25.
Homepage». Journal of the American Society of Hypertension Website. Retrieved 2018-09-25.